Europe Hemophilia Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Type (Hemophilia A, Hemophilia B), By Treatment Type (Prophylaxis, On-demand, and Cure), By Therapy, By Country and Growth Forecast, 2023 - 2030

• Takeda Pharmaceutical Company Limited
• CSL Limited (CSL Behring)
• Pfizer Inc.
• Bayer AG
• F. Hoffmann-La Roche Ltd.
• Novo Nordisk A/S
• Octapharma AG
• BioMarin Pharmaceutical Inc.
• Swedish Orphan Biovitrum AB (Investor AB)
• Sanofi S.A.